LEADER 01611nam  2200445   450 
001 000017095
005 20120411082632.0
010   $a0-12-182241-9
011   $a0076-6879
100   $a20031211d2001----km-y0itay0103----ba
101 0 $aeng
102   $aUS
200 1 $aDrug-nucleic acid interactions$fedited by Jonathan B. Chaires, Michael J. Waring
210   $aSan Diego... [etc.]$cAcademic Press$dc2001
215   $aXXXIV, 705 p., [1] c. di tav.$cill. (alcune color.)$d24 cm
225 2 $aMethods in enzymology$v340
410  1$12001$aMethods in enzymology$v340
606 1 $aAcidi nucleici$xModelli molecolari
606 2 $aFarmaci$xModelli molecolari
676   $a571.6$v(21. ed.)$9Biologia cellulare
676   $a572.8$v(21. ed.)$9Genetica biochimica
702  1$aChaires,$bJonathan B.
702  1$aWaring,$bMichael J.
801  0$aIT$bUniversità della Basilicata - B.I.A.$gRICA$2unimarc
912   $a000017095
996   $aDrug-nucleic acid interactions$984841
997   $aUNIBAS
BAS   $aAGRARIA
CAT   $aSTD031$b01$c20031211$lBAS01$h1252
CAT   $c20050601$lBAS01$h1756
CAT   $abatch$b01$c20050718$lBAS01$h1053
CAT   $c20050718$lBAS01$h1112
CAT   $c20050718$lBAS01$h1142
CAT   $c20050718$lBAS01$h1156
CAT   $aTTM$b30$c20051207$lBAS01$h1236
CAT   $aTTM$b30$c20060714$lBAS01$h1328
CAT   $aTTM$b30$c20060717$lBAS01$h1107
CAT   $aTTM$b30$c20120411$lBAS01$h0826
FMT   
Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$3PTS$698582$5T98582$820051207$f98$FConsultazione